| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hepatitis E | 30 | 2019 | 319 | 8.86 | Why? |
| Hepatitis E virus | 25 | 2019 | 306 | 5.26 | Why? |
| Automation, Laboratory | 8 | 2018 | 536 | 2.12 | Why? |
| Receptors, HIV | 4 | 2018 | 15 | 1.42 | Why? |
| HIV-1 | 16 | 2019 | 3365 | 1.34 | Why? |
| Molecular Diagnostic Techniques | 8 | 2020 | 4239 | 1.23 | Why? |
| Genotyping Techniques | 2 | 2018 | 360 | 1.11 | Why? |
| Ribavirin | 12 | 2019 | 1182 | 1.09 | Why? |
| Drug Resistance, Viral | 7 | 2019 | 1083 | 1.05 | Why? |
| High-Throughput Nucleotide Sequencing | 4 | 2018 | 3633 | 0.97 | Why? |
| Hepatitis Antibodies | 5 | 2019 | 100 | 0.94 | Why? |
| pol Gene Products, Human Immunodeficiency Virus | 2 | 2018 | 39 | 0.93 | Why? |
| Genotype | 17 | 2019 | 4697 | 0.92 | Why? |
| Virology | 2 | 2020 | 489 | 0.88 | Why? |
| Hepatitis, Chronic | 6 | 2019 | 53 | 0.75 | Why? |
| France | 18 | 2021 | 12074 | 0.74 | Why? |
| Organ Transplantation | 8 | 2021 | 2616 | 0.74 | Why? |
| Transfusion Reaction | 2 | 2019 | 245 | 0.73 | Why? |
| Multiplex Polymerase Chain Reaction | 2 | 2018 | 1439 | 0.71 | Why? |
| Jaundice | 1 | 2019 | 114 | 0.70 | Why? |
| Membrane Lipids | 1 | 2017 | 91 | 0.66 | Why? |
| Real-Time Polymerase Chain Reaction | 7 | 2018 | 11367 | 0.66 | Why? |
| HIV Infections | 16 | 2019 | 11620 | 0.65 | Why? |
| Zika Virus | 3 | 2018 | 1924 | 0.63 | Why? |
| Cell-Derived Microparticles | 1 | 2017 | 134 | 0.61 | Why? |
| Viral Load | 15 | 2018 | 15850 | 0.60 | Why? |
| Viremia | 3 | 2018 | 1020 | 0.60 | Why? |
| Picornaviridae Infections | 1 | 2021 | 544 | 0.60 | Why? |
| RNA, Viral | 27 | 2021 | 32276 | 0.58 | Why? |
| Blood Transfusion | 5 | 2018 | 1399 | 0.57 | Why? |
| Chikungunya virus | 1 | 2018 | 339 | 0.57 | Why? |
| Genetic Variation | 3 | 2018 | 3919 | 0.55 | Why? |
| Reverse Transcriptase Inhibitors | 3 | 2018 | 309 | 0.50 | Why? |
| Genes, Viral | 5 | 2018 | 1428 | 0.50 | Why? |
| Immunoassay | 2 | 2020 | 4485 | 0.49 | Why? |
| Plasma | 4 | 2019 | 1809 | 0.48 | Why? |
| Hepatitis C | 9 | 2018 | 1514 | 0.48 | Why? |
| DNA, Viral | 4 | 2018 | 2521 | 0.47 | Why? |
| Papillomaviridae | 1 | 2016 | 404 | 0.47 | Why? |
| Epidemics | 3 | 2021 | 6407 | 0.46 | Why? |
| Cytomegalovirus Infections | 2 | 2016 | 667 | 0.45 | Why? |
| Receptors, CXCR4 | 3 | 2018 | 83 | 0.45 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2021 | 1234 | 0.44 | Why? |
| Mutation | 9 | 2021 | 12376 | 0.44 | Why? |
| Hepacivirus | 6 | 2018 | 1509 | 0.43 | Why? |
| Blood Donors | 4 | 2019 | 2956 | 0.43 | Why? |
| Anti-HIV Agents | 5 | 2019 | 2209 | 0.43 | Why? |
| Exosomes | 1 | 2017 | 567 | 0.43 | Why? |
| Dengue Virus | 1 | 2018 | 910 | 0.43 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2021 | 1261 | 0.42 | Why? |
| Geriatrics | 1 | 2020 | 947 | 0.40 | Why? |
| Transplant Recipients | 13 | 2021 | 4982 | 0.40 | Why? |
| Feces | 5 | 2019 | 4235 | 0.39 | Why? |
| Zika Virus Infection | 3 | 2018 | 1920 | 0.39 | Why? |
| Microbial Sensitivity Tests | 1 | 2018 | 2886 | 0.38 | Why? |
| Saliva | 2 | 2021 | 4679 | 0.35 | Why? |
| Papillomavirus Infections | 1 | 2016 | 861 | 0.34 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 7868 | 0.34 | Why? |
| Humans | 95 | 2021 | 930598 | 0.33 | Why? |
| Sensitivity and Specificity | 13 | 2021 | 22971 | 0.33 | Why? |
| Zoonoses | 3 | 2017 | 3034 | 0.33 | Why? |
| Diagnostic Tests, Routine | 1 | 2018 | 2643 | 0.32 | Why? |
| Kidney Transplantation | 10 | 2021 | 5397 | 0.31 | Why? |
| Hepatitis B virus | 3 | 2018 | 882 | 0.31 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2020 | 3388 | 0.30 | Why? |
| Brachial Plexus Neuritis | 2 | 2017 | 130 | 0.30 | Why? |
| Antiviral Agents | 17 | 2020 | 41703 | 0.30 | Why? |
| Interferon-alpha | 2 | 2012 | 1442 | 0.29 | Why? |
| Polyethylene Glycols | 1 | 2010 | 574 | 0.29 | Why? |
| Water Microbiology | 2 | 2018 | 248 | 0.29 | Why? |
| Emergency Medicine | 1 | 2014 | 936 | 0.27 | Why? |
| Herpesvirus 2, Human | 1 | 2004 | 137 | 0.26 | Why? |
| Aging | 1 | 2020 | 3581 | 0.25 | Why? |
| Th17 Cells | 2 | 2019 | 657 | 0.24 | Why? |
| Immunocompromised Host | 8 | 2021 | 5150 | 0.24 | Why? |
| Treatment Failure | 5 | 2019 | 2106 | 0.24 | Why? |
| Herpesvirus 1, Human | 1 | 2004 | 286 | 0.22 | Why? |
| HIV Reverse Transcriptase | 2 | 2018 | 104 | 0.22 | Why? |
| Herpes Simplex | 1 | 2004 | 272 | 0.22 | Why? |
| HIV Protease | 2 | 2018 | 86 | 0.21 | Why? |
| Viruses | 1 | 2014 | 2238 | 0.21 | Why? |
| Coronavirus | 2 | 2020 | 18339 | 0.21 | Why? |
| Health Policy | 1 | 2021 | 6242 | 0.21 | Why? |
| Chemokine CCL20 | 2 | 2019 | 47 | 0.21 | Why? |
| Sustained Virologic Response | 2 | 2019 | 378 | 0.21 | Why? |
| Hepatitis Antigens | 1 | 2019 | 6 | 0.21 | Why? |
| Reagent Kits, Diagnostic | 3 | 2020 | 2149 | 0.21 | Why? |
| Antiretroviral Therapy, Highly Active | 4 | 2018 | 952 | 0.20 | Why? |
| Seroepidemiologic Studies | 3 | 2021 | 10017 | 0.19 | Why? |
| Hepatitis B | 2 | 2018 | 888 | 0.19 | Why? |
| Viral Tropism | 2 | 2018 | 1329 | 0.19 | Why? |
| Receptors, CXCR3 | 1 | 2019 | 159 | 0.19 | Why? |
| Intestine, Small | 2 | 2019 | 336 | 0.19 | Why? |
| Burkina Faso | 1 | 2019 | 302 | 0.18 | Why? |
| Liver Cirrhosis | 3 | 2018 | 1810 | 0.18 | Why? |
| Polyradiculoneuropathy | 1 | 2017 | 32 | 0.18 | Why? |
| Rilpivirine | 1 | 2018 | 65 | 0.18 | Why? |
| Hepevirus | 1 | 2017 | 17 | 0.18 | Why? |
| Gene Duplication | 1 | 2017 | 31 | 0.18 | Why? |
| Drug Resistance, Multiple, Viral | 1 | 2017 | 37 | 0.17 | Why? |
| Hepatitis C, Chronic | 2 | 2017 | 973 | 0.17 | Why? |
| Viral Hepatitis Vaccines | 1 | 2017 | 58 | 0.17 | Why? |
| Retreatment | 1 | 2017 | 186 | 0.17 | Why? |
| Epidemiologic Methods | 1 | 2021 | 392 | 0.17 | Why? |
| Interleukin-18 | 1 | 2019 | 328 | 0.17 | Why? |
| Phylogeny | 6 | 2018 | 13341 | 0.17 | Why? |
| Tumor Virus Infections | 1 | 2018 | 127 | 0.17 | Why? |
| Maternal-Fetal Exchange | 1 | 2018 | 209 | 0.17 | Why? |
| Communicable Disease Control | 3 | 2021 | 29620 | 0.16 | Why? |
| Male | 36 | 2021 | 367725 | 0.16 | Why? |
| BK Virus | 1 | 2018 | 135 | 0.16 | Why? |
| Hepatocytes | 2 | 2017 | 549 | 0.16 | Why? |
| Virus Diseases | 1 | 2014 | 3779 | 0.16 | Why? |
| Polyomavirus Infections | 1 | 2018 | 156 | 0.16 | Why? |
| Food Microbiology | 1 | 2017 | 114 | 0.16 | Why? |
| Adult | 27 | 2021 | 244371 | 0.16 | Why? |
| Receptors, CCR6 | 1 | 2016 | 45 | 0.16 | Why? |
| Cryoglobulinemia | 1 | 2018 | 144 | 0.16 | Why? |
| Transplants | 1 | 2018 | 136 | 0.16 | Why? |
| Antibodies, Viral | 6 | 2021 | 51949 | 0.16 | Why? |
| Polymerase Chain Reaction | 2 | 2017 | 6740 | 0.16 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.16 | Why? |
| CD4 Lymphocyte Count | 4 | 2019 | 1517 | 0.16 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.15 | Why? |
| Hep G2 Cells | 1 | 2017 | 391 | 0.15 | Why? |
| Iatrogenic Disease | 1 | 2018 | 304 | 0.15 | Why? |
| Middle Aged | 29 | 2021 | 270681 | 0.15 | Why? |
| Hepatitis, Viral, Animal | 1 | 2017 | 274 | 0.15 | Why? |
| Immunogenicity, Vaccine | 2 | 2021 | 4624 | 0.15 | Why? |
| Polyneuropathies | 1 | 2017 | 157 | 0.15 | Why? |
| False Positive Reactions | 1 | 2021 | 1338 | 0.15 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.15 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.15 | Why? |
| RNA Virus Infections | 1 | 2017 | 231 | 0.14 | Why? |
| Female | 32 | 2021 | 380317 | 0.14 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.14 | Why? |
| Capsid Proteins | 1 | 2017 | 365 | 0.14 | Why? |
| Liver | 4 | 2019 | 4007 | 0.14 | Why? |
| Prevalence | 4 | 2021 | 25773 | 0.14 | Why? |
| Base Sequence | 3 | 2017 | 3581 | 0.14 | Why? |
| Enterovirus | 1 | 2018 | 402 | 0.13 | Why? |
| Chikungunya Fever | 1 | 2018 | 345 | 0.13 | Why? |
| Blood Safety | 1 | 2019 | 459 | 0.13 | Why? |
| Intestinal Mucosa | 2 | 2019 | 1046 | 0.13 | Why? |
| Immunoglobulin M | 4 | 2019 | 9091 | 0.13 | Why? |
| Rabbits | 1 | 2017 | 1171 | 0.13 | Why? |
| Respiratory Tract Infections | 1 | 2014 | 6817 | 0.13 | Why? |
| Limit of Detection | 2 | 2018 | 2698 | 0.13 | Why? |
| Erythrocytes | 1 | 2019 | 617 | 0.12 | Why? |
| Models, Statistical | 2 | 2021 | 5312 | 0.12 | Why? |
| Living Donors | 1 | 2018 | 652 | 0.12 | Why? |
| Anti-Retroviral Agents | 2 | 2019 | 1099 | 0.12 | Why? |
| Prospective Studies | 7 | 2020 | 43301 | 0.12 | Why? |
| Cyclohexanes | 1 | 2012 | 43 | 0.12 | Why? |
| Muscular Diseases | 1 | 2017 | 392 | 0.12 | Why? |
| Lung | 1 | 2021 | 31049 | 0.12 | Why? |
| Interferon-gamma | 2 | 2019 | 2711 | 0.12 | Why? |
| Lymphoma | 1 | 2017 | 522 | 0.12 | Why? |
| Immunoglobulin G | 5 | 2019 | 21571 | 0.11 | Why? |
| HIV Fusion Inhibitors | 1 | 2012 | 80 | 0.11 | Why? |
| Reproducibility of Results | 2 | 2020 | 11304 | 0.11 | Why? |
| Plasma Exchange | 1 | 2018 | 763 | 0.11 | Why? |
| Zinc | 1 | 2019 | 817 | 0.11 | Why? |
| Drug Administration Schedule | 3 | 2019 | 2324 | 0.11 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2021 | 13720 | 0.11 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.11 | Why? |
| Virus Internalization | 1 | 2009 | 7921 | 0.11 | Why? |
| Public Health | 3 | 2021 | 16359 | 0.11 | Why? |
| Hepatitis B, Chronic | 1 | 2017 | 616 | 0.10 | Why? |
| Kidney Diseases | 3 | 2018 | 1434 | 0.10 | Why? |
| Europe | 8 | 2018 | 12702 | 0.10 | Why? |
| Carcinoma, Hepatocellular | 2 | 2017 | 1222 | 0.10 | Why? |
| Recombination, Genetic | 1 | 2017 | 1265 | 0.10 | Why? |
| Animals | 9 | 2019 | 78931 | 0.10 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.10 | Why? |
| Viral Proteins | 2 | 2019 | 7370 | 0.10 | Why? |
| Immunity | 1 | 2021 | 2651 | 0.10 | Why? |
| T-Lymphocytes, Regulatory | 1 | 2016 | 698 | 0.10 | Why? |
| Early Diagnosis | 1 | 2018 | 2443 | 0.10 | Why? |
| Viral Nonstructural Proteins | 2 | 2018 | 4810 | 0.10 | Why? |
| env Gene Products, Human Immunodeficiency Virus | 2 | 2010 | 386 | 0.10 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.10 | Why? |
| Renal Dialysis | 4 | 2021 | 4358 | 0.10 | Why? |
| Aged | 12 | 2021 | 215776 | 0.09 | Why? |
| Serologic Tests | 3 | 2018 | 4359 | 0.09 | Why? |
| Phenotype | 2 | 2017 | 4037 | 0.09 | Why? |
| Seizures | 1 | 2017 | 1163 | 0.09 | Why? |
| Mice, SCID | 2 | 2019 | 225 | 0.09 | Why? |
| Seasons | 1 | 2021 | 4071 | 0.09 | Why? |
| Disease Reservoirs | 1 | 2017 | 1672 | 0.09 | Why? |
| Hospitals, University | 1 | 2020 | 4173 | 0.09 | Why? |
| Triazoles | 1 | 2012 | 440 | 0.08 | Why? |
| Kinetics | 3 | 2020 | 3238 | 0.08 | Why? |
| Whole Genome Sequencing | 1 | 2018 | 3239 | 0.08 | Why? |
| Heart Transplantation | 1 | 2017 | 1293 | 0.08 | Why? |
| Waste Water | 1 | 2018 | 2185 | 0.08 | Why? |
| Health Personnel | 3 | 2021 | 29646 | 0.08 | Why? |
| Child | 4 | 2021 | 70012 | 0.08 | Why? |
| Semen | 1 | 2012 | 550 | 0.08 | Why? |
| Drug Therapy, Combination | 4 | 2018 | 7268 | 0.08 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.08 | Why? |
| Dengue | 1 | 2018 | 1565 | 0.07 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.07 | Why? |
| Environmental Monitoring | 1 | 2018 | 3143 | 0.07 | Why? |
| Disease Models, Animal | 3 | 2019 | 10998 | 0.07 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.07 | Why? |
| Chronic Disease | 5 | 2019 | 5139 | 0.07 | Why? |
| Risk | 1 | 2017 | 5288 | 0.07 | Why? |
| Secondary Prevention | 1 | 2010 | 762 | 0.07 | Why? |
| Renal Insufficiency, Chronic | 1 | 2018 | 2654 | 0.07 | Why? |
| Cells, Cultured | 2 | 2018 | 5835 | 0.07 | Why? |
| Child, Preschool | 2 | 2021 | 36283 | 0.07 | Why? |
| Longitudinal Studies | 4 | 2018 | 9893 | 0.06 | Why? |
| Evolution, Molecular | 1 | 2017 | 3691 | 0.06 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.06 | Why? |
| Virus Attachment | 1 | 2010 | 1259 | 0.06 | Why? |
| Computational Biology | 1 | 2018 | 4514 | 0.06 | Why? |
| Virus Replication | 3 | 2019 | 14331 | 0.06 | Why? |
| Sequence Analysis, DNA | 3 | 2018 | 2830 | 0.06 | Why? |
| Cytopathogenic Effect, Viral | 1 | 2004 | 635 | 0.06 | Why? |
| Vaccines | 1 | 2021 | 3692 | 0.06 | Why? |
| Kidney Failure, Chronic | 1 | 2018 | 3222 | 0.06 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.06 | Why? |
| Brain Ischemia | 1 | 2017 | 2813 | 0.06 | Why? |
| Developing Countries | 1 | 2017 | 4283 | 0.06 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2018 | 5164 | 0.05 | Why? |
| Specimen Handling | 1 | 2018 | 6190 | 0.05 | Why? |
| Recombinant Proteins | 2 | 2010 | 3786 | 0.05 | Why? |
| Abatacept | 1 | 2021 | 192 | 0.05 | Why? |
| DNA Primers | 1 | 2004 | 1170 | 0.05 | Why? |
| Leukocytes, Mononuclear | 1 | 2009 | 2115 | 0.05 | Why? |
| Chemokine CXCL11 | 1 | 2019 | 48 | 0.05 | Why? |
| Vaccine Potency | 1 | 2021 | 339 | 0.05 | Why? |
| Cohort Studies | 3 | 2020 | 36005 | 0.05 | Why? |
| Chemokines, CC | 1 | 2019 | 79 | 0.05 | Why? |
| Cross Infection | 2 | 2018 | 8675 | 0.05 | Why? |
| Nervous System Diseases | 1 | 2018 | 4092 | 0.05 | Why? |
| Decidua | 1 | 2018 | 32 | 0.05 | Why? |
| Chemokine CXCL9 | 1 | 2019 | 154 | 0.05 | Why? |
| Stromal Cells | 1 | 2018 | 105 | 0.04 | Why? |
| Pregnancy | 2 | 2018 | 23879 | 0.04 | Why? |
| Transaminases | 1 | 2018 | 152 | 0.04 | Why? |
| Asymptomatic Infections | 1 | 2017 | 7218 | 0.04 | Why? |
| Age Factors | 1 | 2019 | 21039 | 0.04 | Why? |
| Retrospective Studies | 5 | 2021 | 105322 | 0.04 | Why? |
| Brachial Plexus | 1 | 2017 | 28 | 0.04 | Why? |
| Interleukin Receptor Common gamma Subunit | 1 | 2017 | 24 | 0.04 | Why? |
| Foodborne Diseases | 1 | 2018 | 89 | 0.04 | Why? |
| HIV Integrase | 1 | 2017 | 67 | 0.04 | Why? |
| RNA, Messenger | 2 | 2021 | 5131 | 0.04 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.04 | Why? |
| HIV Seropositivity | 1 | 2019 | 320 | 0.04 | Why? |
| Treatment Outcome | 5 | 2018 | 51732 | 0.04 | Why? |
| Feedback, Physiological | 1 | 2016 | 56 | 0.04 | Why? |
| Chemotaxis | 1 | 2016 | 67 | 0.04 | Why? |
| Enzyme-Linked Immunospot Assay | 1 | 2017 | 325 | 0.04 | Why? |
| Genome, Viral | 1 | 2018 | 13157 | 0.04 | Why? |
| Pilot Projects | 2 | 2018 | 5182 | 0.04 | Why? |
| Genetic Loci | 1 | 2017 | 439 | 0.04 | Why? |
| Cell Movement | 1 | 2019 | 695 | 0.04 | Why? |
| DNA Mutational Analysis | 1 | 2018 | 581 | 0.04 | Why? |
| Postoperative Period | 1 | 2017 | 651 | 0.04 | Why? |
| Kidney | 3 | 2018 | 3648 | 0.04 | Why? |
| Darunavir | 1 | 2018 | 477 | 0.04 | Why? |
| Chemokine CXCL10 | 1 | 2019 | 565 | 0.04 | Why? |
| Forkhead Transcription Factors | 1 | 2016 | 231 | 0.04 | Why? |
| Global Health | 1 | 2018 | 13911 | 0.04 | Why? |
| Statistics as Topic | 1 | 2017 | 370 | 0.03 | Why? |
| Allografts | 1 | 2018 | 761 | 0.03 | Why? |
| CD4 Antigens | 1 | 2016 | 306 | 0.03 | Why? |
| Data Interpretation, Statistical | 1 | 2018 | 657 | 0.03 | Why? |
| Neurologic Examination | 1 | 2017 | 428 | 0.03 | Why? |
| Graft Survival | 1 | 2017 | 587 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2021 | 25144 | 0.03 | Why? |
| Mice | 3 | 2019 | 21357 | 0.03 | Why? |
| Case-Control Studies | 3 | 2018 | 17671 | 0.03 | Why? |
| Liver Transplantation | 1 | 2010 | 2864 | 0.03 | Why? |
| DNA-Binding Proteins | 1 | 2017 | 469 | 0.03 | Why? |
| Enterocytes | 1 | 2016 | 245 | 0.03 | Why? |
| Transforming Growth Factor beta | 1 | 2016 | 363 | 0.03 | Why? |
| Th1 Cells | 1 | 2019 | 1228 | 0.03 | Why? |
| Enterovirus Infections | 1 | 2018 | 404 | 0.03 | Why? |
| China | 1 | 2020 | 50654 | 0.03 | Why? |
| Infant, Newborn | 1 | 2014 | 23105 | 0.03 | Why? |
| Cell Culture Techniques | 1 | 2017 | 704 | 0.03 | Why? |
| Antibody Affinity | 1 | 2017 | 1078 | 0.03 | Why? |
| Glomerular Filtration Rate | 1 | 2018 | 1262 | 0.03 | Why? |
| Sperm Count | 1 | 2012 | 72 | 0.03 | Why? |
| Infant | 1 | 2014 | 30274 | 0.03 | Why? |
| Immunosuppressive Agents | 2 | 2021 | 6331 | 0.03 | Why? |
| Pregnancy Complications, Infectious | 1 | 2017 | 11559 | 0.03 | Why? |
| Diagnostic Errors | 1 | 2017 | 865 | 0.03 | Why? |
| Killer Cells, Natural | 1 | 2021 | 2093 | 0.03 | Why? |
| Interleukin-17 | 1 | 2016 | 602 | 0.03 | Why? |
| Liver Function Tests | 1 | 2017 | 1325 | 0.03 | Why? |
| Ganciclovir | 1 | 2010 | 97 | 0.03 | Why? |
| Intersectoral Collaboration | 1 | 2017 | 1065 | 0.03 | Why? |
| Polymorphism, Genetic | 1 | 2017 | 1074 | 0.02 | Why? |
| Emergency Service, Hospital | 1 | 2014 | 14232 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2004 | 9537 | 0.02 | Why? |
| Risk Factors | 4 | 2019 | 71621 | 0.02 | Why? |
| Molecular Sequence Data | 2 | 2010 | 3198 | 0.02 | Why? |
| Interleukin-10 | 1 | 2016 | 1409 | 0.02 | Why? |
| Swine | 1 | 2018 | 3352 | 0.02 | Why? |
| Vaccines, Synthetic | 1 | 2021 | 3231 | 0.02 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.02 | Why? |
| Netherlands | 1 | 2017 | 3533 | 0.02 | Why? |
| Fatal Outcome | 1 | 2017 | 3438 | 0.02 | Why? |
| Graft Rejection | 1 | 2018 | 1766 | 0.02 | Why? |
| Environmental Exposure | 1 | 2018 | 1558 | 0.02 | Why? |
| Bayes Theorem | 1 | 2017 | 3237 | 0.02 | Why? |
| Multiple Organ Failure | 1 | 2017 | 1724 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
| Acute Disease | 1 | 2019 | 6029 | 0.02 | Why? |
| Interferons | 1 | 2018 | 2885 | 0.02 | Why? |
| Cross Reactions | 1 | 2017 | 4374 | 0.02 | Why? |
| Incidence | 2 | 2018 | 25622 | 0.02 | Why? |
| Liver Neoplasms | 1 | 2017 | 1666 | 0.02 | Why? |
| Viral Envelope Proteins | 1 | 2017 | 3539 | 0.02 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2019 | 4545 | 0.02 | Why? |
| Lopinavir | 1 | 2018 | 4308 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2016 | 4758 | 0.02 | Why? |
| T-Lymphocytes | 1 | 2021 | 6670 | 0.02 | Why? |
| Ritonavir | 1 | 2018 | 4212 | 0.02 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2016 | 4020 | 0.02 | Why? |
| Antibodies, Monoclonal | 1 | 2021 | 8041 | 0.01 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2019 | 5837 | 0.01 | Why? |
| Interferon Type I | 1 | 1995 | 2789 | 0.01 | Why? |
| Biopsy | 2 | 2002 | 2811 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2019 | 17020 | 0.01 | Why? |
| Occupational Exposure | 1 | 2018 | 4742 | 0.01 | Why? |
| Signal Transduction | 1 | 2016 | 7207 | 0.01 | Why? |
| Cytokines | 1 | 2019 | 15010 | 0.01 | Why? |
| Mass Screening | 1 | 2017 | 8005 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.01 | Why? |
| United Kingdom | 1 | 2017 | 18046 | 0.01 | Why? |
| Quality of Life | 1 | 2018 | 9820 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2017 | 11041 | 0.01 | Why? |
| gamma-Glutamyltransferase | 1 | 1995 | 101 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2018 | 9044 | 0.01 | Why? |
| Severity of Illness Index | 2 | 2019 | 48226 | 0.01 | Why? |
| Histocompatibility Testing | 1 | 1995 | 219 | 0.01 | Why? |
| Azathioprine | 1 | 1995 | 161 | 0.01 | Why? |
| Postoperative Complications | 1 | 2013 | 5861 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.01 | Why? |
| Critical Illness | 1 | 2017 | 17281 | 0.01 | Why? |
| Cyclosporine | 1 | 1995 | 449 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2018 | 53120 | 0.01 | Why? |
| Alanine Transaminase | 1 | 1995 | 1329 | 0.01 | Why? |
| Creatinine | 1 | 1995 | 1443 | 0.01 | Why? |
| Disease Progression | 1 | 2002 | 13580 | 0.00 | Why? |